Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 2/20 | 0.36 |
| ▸ | TGM2 | P21980 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17829164 | 0.97 | PTGES (0.36) | NT5ETGM2ABCG2ADORA2AUSP2 | |
| SCHEMBL17829180 | 0.95 | PTGES (0.35) | NT5ETGM2ABCG2ADORA2AUSP2 | |
| SCHEMBL17829143 | 0.95 | PTGES (0.35) | NT5ETGM2ABCG2ADORA2AUSP2 | |
| SCHEMBL17829018 | 0.93 | PTGES (0.39) | ABCG2TSHRHSD17B10PTGES | |
| SCHEMBL17829039 | 0.90 | PTGES (0.37) | PTGES | |
| SCHEMBL17828937 | 0.90 | PTGES (0.37) | ABCG2TSHRHSD17B10PTGES | |
| SCHEMBL17829197 | 0.89 | ABCG2 (0.35) | NT5EABCG2ADORA2AUSP2CYP1A2 | |
| SCHEMBL17829010 | 0.89 | PTGES (0.39) | ABCG2TSHRHSD17B10PTGES | |
| SCHEMBL17828906 | 0.89 | PTGES (0.37) | ABCG2TSHRHSD17B10PTGES | |
| SCHEMBL17828936 | 0.88 | PTGES (0.39) | TSHRHSD17B10PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9508939-B2 | Compound and organic electroluminescent element produced using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9508939-B2 | Compound and organic electroluminescent element produced using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-29 | — | — | US | disclosed |
| US-20160172604-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160172604-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172604-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME | L1CAM, LEF1, EML4 | NT5E 4042/4885TGM2 1586/4885ABCG2 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.